acetylcysteine has been researched along with Leukomalacia, Periventricular in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Almazan, G; Fragoso, G; Khorchid, A; Shore, G | 1 |
Barbosa, E; Paintlia, AS; Paintlia, MK; Singh, AK; Singh, I | 1 |
2 other study(ies) available for acetylcysteine and Leukomalacia, Periventricular
Article | Year |
---|---|
Catecholamine-induced oligodendrocyte cell death in culture is developmentally regulated and involves free radical generation and differential activation of caspase-3.
Topics: Acetylcysteine; Animals; Animals, Newborn; Apoptosis; Asphyxia Neonatorum; Brain; Caspase 3; Caspases; Catecholamines; Cell Differentiation; Cells, Cultured; Enzyme Inhibitors; Free Radicals; Genes, bcl-2; Glutathione; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Humans; Infant, Newborn; Leukomalacia, Periventricular; Membrane Proteins; Oligodendroglia; Oxidative Stress; Poly(ADP-ribose) Polymerases; Rats; Rats, Sprague-Dawley; Stem Cells | 2002 |
N-acetylcysteine prevents endotoxin-induced degeneration of oligodendrocyte progenitors and hypomyelination in developing rat brain.
Topics: 2',3'-Cyclic-Nucleotide Phosphodiesterases; Acetylcysteine; Age Factors; Analysis of Variance; Animals; Animals, Newborn; Antigens; CD11b Antigen; Cell Count; Cell Death; Cytokines; Demyelinating Diseases; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Embryo, Mammalian; Female; Humans; Immunohistochemistry; In Situ Nick-End Labeling; Infant, Newborn; Leukomalacia, Periventricular; Lipopolysaccharides; Male; Myelin Basic Protein; Nerve Degeneration; Neuroprotective Agents; O Antigens; Oligodendroglia; Pregnancy; Proteoglycans; Rats; Rats, Sprague-Dawley; Receptor, Platelet-Derived Growth Factor alpha; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stem Cells; Survival Rate; Time Factors; Transcription Factors | 2004 |